Skip to main content
. 2016 Dec 15;2016(12):CD006918. doi: 10.1002/14651858.CD006918.pub3

NCT 00694707.

Methods Allocation: randomised.
 Blindness: double.
Duration: 6 weeks.
 Design: parallel.
Participants Diagnosis: people with schizophrenia.
Interventions 1. Risperidone: dose 4 mg/day.
 2. Placebo.
3. Cariprazine 1.5 mg/d.
4. Cariprazine 3 mg/d.
5. Cariprazine 4.5 mg/d.
Outcomes Not reported.
Notes Awaiting for full text.